Thyroid hormone receptors are encoded by the TR␣ (NR1A1) and TR␤ (NR1A2) loci. These genes are transcribed into multiple variants whose functions are unclear. Analysis by gene inactivation in mice has provided new insights into the functional complexity of these products. Different strategies designed to modify the TR␣ locus have led to strikingly different phenotypes. In order to analyze the molecular basis for these alterations, we generated mice devoid of all known isoforms produced from the TR␣ locus (TR␣ 0/0 ). These mice are viable and exhibit reduced linear growth, bone maturation delay, moderate hypothermia, and reduced thickness of the intestinal mucosa. Compounding TR␣ 0 and TR␤ ؊ mutations produces viable TR␣ 0/0 ␤ ؊/؊ mice, which display a more severe linear growth reduction and a more profound hypothermia as well as impaired hearing. A striking phenotypic difference is observed between TR␣ 0/0 and the previously described TR␣ ؊/؊ mice, which retain truncated TR⌬␣ isoforms arising from a newly described promoter in intron 7. The lethality and severe impairment of the intestinal maturation in TR␣ ؊/؊ mice are rescued in TR␣ 0/0 animals. We demonstrate that the TR⌬␣ protein isoforms, which are natural products of the TR␣ locus, are the key determinants of these phenotypical differences. These data reveal the functional importance of the non-T3-binding variants encoded by the TR␣ locus in vertebrate postnatal development and homeostasis.
Thyroid hormone receptors are encoded by the TR␣ (NR1A1) and TR␤ (NR1A2) loci. These genes are transcribed into multiple variants whose functions are unclear. Analysis by gene inactivation in mice has provided new insights into the functional complexity of these products. Different strategies designed to modify the TR␣ locus have led to strikingly different phenotypes. In order to analyze the molecular basis for these alterations, we generated mice devoid of all known isoforms produced from the TR␣ locus (TR␣ 0/0 ). These mice are viable and exhibit reduced linear growth, bone maturation delay, moderate hypothermia, and reduced thickness of the intestinal mucosa. Compounding TR␣ 0 and TR␤ ؊ mutations produces viable TR␣ 0/0 ␤ ؊/؊ mice, which display a more severe linear growth reduction and a more profound hypothermia as well as impaired hearing. A striking phenotypic difference is observed between TR␣ 0/0 and the previously described TR␣ ؊/؊ mice, which retain truncated TR⌬␣ isoforms arising from a newly described promoter in intron 7. The lethality and severe impairment of the intestinal maturation in TR␣ ؊/؊ mice are rescued in TR␣ 0/0 animals. We demonstrate that the TR⌬␣ protein isoforms, which are natural products of the TR␣ locus, are the key determinants of these phenotypical differences. These data reveal the functional importance of the non-T3-binding variants encoded by the TR␣ locus in vertebrate postnatal development and homeostasis.
Thyroid hormone receptors (TRs), encoded by the TR␣ and TR␤ loci, mediate the action of triiodothyronine (T3) in all vertebrates. These nuclear proteins activate or repress the transcription of target genes by recruiting several protein complexes which modify the structure of chromatin (15) . In mammals, T3 exerts homeostatic and developmental functions. Thyroid hormone (TH) deprivation leads to developmental (growth retardation, impaired neurogenesis) (8, 23, 36) or metabolic (reduced oxygen consumption, bradycardia, weakness, fatigue) disorders (13) . Point mutations in the TR␤ gene result in syndromes known as resistance to thyroid hormone (30) . Recently, the introduction of mutations in the genes encoding these receptors in mice has allowed further understanding of the mechanisms mediating the physiological actions of T3 (17, 19) . The TR␤ locus encodes the TR␤1 and TR␤2 receptors. A new receptor, TR␤3, and its non-DNA-binding TR⌬␤3 variant have recently been described. The latter isoforms are proposed to arise from a novel promoter located upstream of the exons encoding the DNA binding domain (41) . Genetic invalidation of the TR␤2 gene leads to pituitary resistance to TH with elevated thyrotropin (TSH) and thyroxine (T4) levels in serum (1) . Knocking out all TR␤1, TR␤2, and TR␤3/⌬␤3 genes reproduces this phenotype (10, 14) but also induces the loss of auditory function, due to delayed expression of a potassium channel in the cochlea (11) , and results in impaired transcriptional response to T3 in liver (38) . The TR␣ locus encodes the ubiquitous TR␣1 receptor and a splice variant, TR␣2, which cannot bind T3 and behaves as a weak inhibitor of TRs in transfection assays (21, 22) . We have previously shown that, in a limited number of tissues, the TR␣ locus also encodes two transcripts, previously characterized by Northern blotting, RNase protection, and reverse transcription (RT)-PCR analysis in embryonic stem (ES) cells, driven by a promoter located in intron 7, which generate TR⌬␣1 and TR⌬␣2 proteins. These proteins do not bind DNA or T3; hence, they are inhibitors of the activities of TRs and retinoic acid receptors in transfection assays (6) . In vivo genetic modifications of the TR␣ locus result in different phenotypes, according to the precise location of the mutation. In TR␣ Ϫ/Ϫ mice, the expression of TR␣1 and TR␣2 transcripts is abolished, but the TR⌬␣ transcripts are still expressed (12) . These mice suffer from hypothyroidism and display several developmental defects, including growth retardation, altered intestinal development (28) , impaired T-and B-lymphocyte maturation (3), expansion of cartilage regions in long bones, and finally growth arrest and death shortly after weaning (12) . Mice which lack the TR␣1 and TR⌬␣1 products (TR␣1 Ϫ/Ϫ ) have been reported to exhibit mild hypothyroxinemia, bradycardia, and lower body temperature, but they display normal growth and life span (39) . The lethal phenotype of TR␣ Ϫ/Ϫ mice compared to the viability of TR␣1 Ϫ/Ϫ mice might be attributed to the deeper hypothyroxinemia of the former. The involvement of TH as the cause of this phenotypic discrepancy can be ruled out. Indeed, although TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ and TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ mice both lack the known TRs and have very high serum levels of TH, TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice die upon weaning (14) , whereas TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ mice are viable (16) . Hence, the phenotypic differences must be ascribed to structural differences between the TR␣ mutant alleles. They could be attributed either to the TR␣2 isoform, which is expressed in TR␣1
Ϫ/Ϫ but not in TR␣ Ϫ/Ϫ mice, or to the balance between the TR␣ and TR⌬␣ isoforms. In an attempt to determine the role of the non-T3-binding products, we have generated a new mouse strain harboring a targeted deletion designed to prevent the expression of all transcripts from the TR␣ locus. In this paper we describe the phenotype of these TR␣ 0/0 mutant mice and point out similarities and striking differences with previously described TR␣1 Ϫ/Ϫ and TR␣ Ϫ/Ϫ mice. This comparative analysis brings a new piece in the genetic analysis of the complex TR␣ locus and sheds new light on the respective functions of the TR␣ products in body growth, bone maturation, thermogenesis, audition, and intestinal maturation.
MATERIALS AND METHODS
Targeted disruption of TR␣ gene. The TR␣ 0 -targeting vector was constructed using pGNA␤ as starting plasmid (gift from P. Brulet, Institut Pasteur, Paris, France). The 3Ј arm homologous to TR␣ was amplified by PCR from ENS ES cell DNA (14) , using the Expand High Fi system (Roche). The 5Ј arm was cloned from a EMBL4 library (gift from J. P Magaud). The thymidine kinase gene was inserted downstream of the 3Ј arm.
ENS ES cells were electroporated with 40 g of linearized targeting vector and then selected with 250 g of G418 (Gibco-BRL) per ml and 0.2 M ganciclovir. Targeted clones were confirmed by Southern blot analysis using PvuII enzyme and a 900-bp PCR fragment extending from the 3Ј end of exon 3 to the 5Ј end of exon 4 of TR␣ as a probe. Two positive clones were injected into blastocysts of C57BL/6 recipient mice. TR␣ 0/ϩ animals were derived in an inbred 129sv background. TR␣ 0/0 mice were obtained by intercrossing heterozygous animals. Mouse breeding and handling were carried out in a certified animal facility, according to procedures approved by the local animal care and use committee.
Purification of RNA, Northern blotting RNase protection assay, and RT-PCR analysis. Total RNA from distal small intestine or pituitary was isolated by the improved acid-guanidine-phenol-chloroform method. For Northern blot analysis, single-stranded DNA probes were generated by a 30-cycle reaction using Taq DNA polymerase from Eurobio using 10 ng of TR␣ (exon 8), growth hormone (GH), or hypoxanthine phosphoribosyltransferase (HPRT) PCR fragments as a template, and 20 ng of a specific antisense primer: oligonucleotides ␣15A (CA GCCTGCAGCAGAGCCACTTCCG), GHa (GTCAAACTTGTCATAGGTT TG), and HPRTa (CACAGGACTAGAACACCTGC) were used as primers to generate the TR␣, GH, and HPRT probes, respectively.
RNase protection was performed using reagents from Ambion (Austin, Tex.) according to the manufacturer's instructions. HPRT and TR␣ cDNA fragments were generated by RT-PCR and inserted into a pGEMt easy vector (Promega). Oligonucleotides HPRTs (GCTGGTGAAAAGGACCTCT) and HPRTa (see above) were used to generate the HPRT fragment, and TR␣Cs (CTCTGTGA TCCTGCTGTTCCACAG) and TR␣1a (CGACTTTCATGTGGAGGAAG) were used to generate the TR␣ cDNA.
RT was performed as described in reference 12. cDNA (0.05 g) was used for each PCR with Eurobio Taq. To allow the detection of TR␣ gene products (TR␣1, TR␣2, TR⌬␣1, and TR⌬␣2) by RT-PCR, we used a sense primer within exon 8 (␣2Ј, CTGCCTTGCGAAGACCAGATC) and an antisense primer within exon 9 (␣3, GCGGTGGTTGACGTAGTGCTC). All the oligonucleotides were purchased from MWG (Ebersberg, Germany). In these preparations, mineralized bone is stained by alizarin red and cartilage is stained by alcian blue 8GX. For mineralization analysis, tibias were dissected out, fixed in 70% alcohol, embedded in paraffin, and cut (7 m), and undecalcified sections were stained according to the standard protocol (26) . For histological analyses, the paired limbs were fixed in 10% neutral buffered formalin for 4 to 6 days and subsequently decalcified for 2 days in 10% formic acid-10% neutral buffered formalin at 20°C. Limbs were embedded in paraffin and 3-m sections were cut, deparaffinized in xylene, and rehydrated. Sections were stained with hematoxylin and eosin or alcian blue 8GX and van Gieson to visualize cartilage matrix mucopolysaccharides in blue and collagen-containing bone osteoid in red, according to standard histological protocols. Body temperature. The system we used, ELAMS (Electronic Laboratory Animal Monitoring System by BioMedic Data Systems, Inc., Seaford, Del.), consisted of implantable programmable temperature transponders (IPTT-100) and a portable data scanner (DAS-5007). The transponders were implanted subcutaneously in the backs of three 8-to 12-week-old males from each genotype. Animals were maintained under anesthesia with midazolam. All animals were kept in a climate-controlled room with 12-h alternating light and dark cycles. Temperature measurements were initiated 3 days after the implantation and were recorded in duplicate at 10 a.m., while the animals were moving freely in their cage with the lid removed, and the scanner was placed within 5 cm of the transponder. Body temperature monitoring continued for up to 7 days.
Temperature was measured rectally at the same time in TR␣ 0/0 ␤ Ϫ/Ϫ by means of a digital recording with a thermistor system. Values were not significantly different from those recorded by the transponder (data not shown).
Growth measurements. Male mice anesthetized with methoxyflurane were weighed and measured (nose to tail base) weekly from 2 to 9 weeks of age. Mice were housed five per cage, and food and water were provided ad libitum. The numbers of mice used from each genotype were as follows: wild type, 19 to 29; TR␤ Ϫ/Ϫ , 6 to 17; and TR␣ 0/0 , 10 to 22. Hormone measurements. Serum T4 and TSH were measured by radioimmunoassays as previously described (29) .
Hearing tests. The auditory brainstem response (ABR) was used to assess the auditory sensitivity by a procedure that has been described in detail elsewhere (35) . Tucker-Davis Technologies (Gainesville, Fla.) hardware and software (AeP and Siggen packages) were employed. Briefly, mice were anesthetized with sodium pentobarbital (Nembutal, 1.2 l per g of body weight intraperitoneally [i.p.]) and chlorprothixene (Taractan, 0.5 l/g i.p.) and kept warm with a heating pad. The average response (waveform) per 100 presentations of tone bursts (1 ms rise and fall; 3 ms duration; rate, 21 Hz; frequencies of 4, 8, 12, 16 , and 24 kHz) was recorded using a subdermal needle electrode placed in the scalp. Each tone frequency was presented in descending intensity steps beginning at 80-dB sound pressure level and ending when a visually discernible ABR waveform could no longer be detected. Thresholds were then determined to within 5 dB for each frequency (35) . The numbers of mice (60 to 90 days old) tested from each genotype were as follows: wild type, 7; TR␤ Ϫ/Ϫ , 9; TR␣ 0/0 , 7; and combined TR␤ Ϫ/Ϫ TR␣ 0/0 , 4. Morphological staining and immunohistochemistry. Three-week-old mice were killed by cervical dislocation and the small intestines were immediately removed. Proximal jejunums and distal ilea were collected separately and fixed in Carson's solution overnight at 4°C. They were then embedded in paraffin and 5-m sections were applied on polylysine-coated slides. For morphological observations, after dewaxing and rehydration, the slides were stained with hematoxylin and eosin.
Immunochemistry experiments were performed with a monoclonal antibody (Novocastra Laboratories) for Ki-67 detection. Polyclonal antibody PAI-211 (Affinity Bioreagents, Inc.) for TR␣1 and TR⌬␣1 protein localization and another recognizing the N-terminal part of both TR␣1 and TR␣2 proteins (generous gift of D. Baas [4] ) were used in combination with secondary biotinylated antibody and streptavidin-peroxidase detection system (Histomouse; Zymed). The tissue was counterstained lightly with hematoxylin. Before incubation with the primary antibody, the slides were immersed in 0.01 M citrate buffer, pH 6, and microwaved for 15 min.
Cells, plasmids, transfections, and Western blotting. HeLa cells were maintained in Dulbecco modified Eagle medium supplemented with 10% fetal calf serum. The plasmids containing the cDNAs of human TR␣1 (pSG5hTR␣1), rat TR␤1 (pSG5rTR␤1), mouse TR⌬␣1 (pSG5mTR⌬␣1), FlagTR⌬␣1 (CMVFmTR⌬␣1), and mouse TR⌬␣2 (pSG5mTR⌬␣2) have been described previously (6) . HeLa cells were transfected using a calcium phosphate procedure as previously described (7) and harvested after 48 h. Lactacystin was a gift from Satoshi Omura (Tokyo, Japan). Western blotting was performed as previously described (6) . We used the no. 21 polyclonal antibody (gift of J. Ghysdael) as described in reference 5 to detect TR␣1 and TR⌬␣1 proteins and the M2 anti-Flag antibody (IBI) to detect the Flag-TR⌬␣1 protein.
RESULTS
The TR␣ 0/0 mutation abolishes the production of all products from the TR␣ locus. To generate mice deprived of any TR␣ gene product (TR␣1 and TR␣2 and their truncated counterparts TR⌬␣1 and TR⌬␣2), a lacZ neo r cassette (12) was introduced by homologous recombination between exon 4 and exon 8 of the TR␣ gene (Fig. 1A) to generate the TR␣ 0 allele (Fig. 1B) . This removed the DNA binding region of TR␣1 and TR␣2, preventing the production of a chimeric protein that could act in a dominant-negative manner upon TR␤. It also removed the internal promoter in intron 7 which has been shown to drive the transcription of TR⌬␣1 and TR⌬␣2 (6) . The TR␣ 0 mutated allele was introduced into ES cells by homologous recombination. The structure of the modified allele was checked by Southern blotting (Fig. 1C) . Two independent positive clones were injected into host blastocysts. Heterozygous mice were derived from an inbred 129Sv genetic background. They were then intercrossed to obtain TR␣ 0/0 mice. We checked for the expression of TR␣ transcripts in wildtype, TR␣ 0/0 , and previously described TR␣ Ϫ/Ϫ mice (12) . This analysis was performed on intestine RNA where the four TR␣ isoforms have been shown to be expressed. Northern blot analysis ( Fig. 2A) showed that all four transcripts could be identified in the distal ileum of wild-type mice. In TR␣ Ϫ/Ϫ mice, TR␣1 and TR␣2 RNAs were undetectable, whereas the TR⌬␣1 and TR⌬␣2 transcripts were still detected. In TR␣ 0/0 mice, neither TR␣ nor TR⌬␣ transcripts were detected. In agreement with these data, RT-PCR did not allow the detection of transcripts containing exons 8 and 9 in the intestines of TR␣ 0/0 mice ( Fig. 2B ). RNase protection analysis ( Fig. 2C ) revealed that the TR␣1 and TR␣2 isoforms, which are highly expressed in wild-type samples, are almost undetectable in TR␣ Ϫ/Ϫ and TR␣ 0/0 samples. Occasionally, the 448-and 386-nucleotide fragments were detected in the mutant mice, corresponding to transcription reading through the stop sites within the lacZ neo r cassette. It is noteworthy that RNase protection showed that wild-type ileum contained similar amounts of TR␣1 and TR␣2 transcripts. Underrepresentation of the large TR␣1 transcript in Northern blot experiments may have been caused by poor transfer onto nylon membranes. Two protected fragments, whose sizes correspond to the TR⌬␣1 and TR⌬␣2 isoforms, were detected in wild-type and TR␣ Ϫ/Ϫ but not in TR␣ 0/0 samples. It is thus concluded that in the distal ileum of wild-type mice, four TR␣ isoforms are expressed, including TR⌬␣1 and TR⌬␣2, which are expressed at much lower levels than TR␣1 and TR␣2. The TR␣ 0 mutation completely abolishes the transcription from the TR␣ locus, in contrast with the TR␣ mutation which still allows the production of TR⌬␣ transcripts, as previously described (Fig. 2D) . TR␣ 0/0 and TR␣ 0/0 ␤ ؊/؊ mice display normal embryonic development and are viable. It has previously been shown that TR␣ Ϫ/Ϫ and TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice were born in Mendelian proportions but died after weaning (12, 14) . Lethality was found in 129SV, BALB/c, and C57BL/6 genetic backgrounds after eight backcrosses. When TR␣ 0/ϩ mice were intercrossed, among 346 born pups, 98 (28.3%), 170 (49%), and 78 (22.5%) were, respectively, wild-type, heterozygous, and homozygous mutant progenies. Unlike the TR␣ Ϫ/Ϫ mice, all TR␣ 0/0 mice survived over the weaning period and the mortality in the adult population was not different from that observed in the wild type. Male and female TR␣ 0/0 mice were fertile. Viability and fertility were observed in C57BL/6 and 129SV backgrounds. mice. The serum levels of T3 and T4 are strictly controlled by the direct hormonal feedback on TSH-releasing hormone (TRH) and TSH secretion, in the hypothalamus and the pituitary, respectively (20, 24, 29) . We and others have previously demonstrated that TR␤ plays a key role in this feedback loop since TR␤ Ϫ/Ϫ mice display high T3, T4, and TSH levels (11, 14, 1). The role of TR␣ in this regulation has not been clearly established. TR␣1
Ϫ/Ϫ mice demonstrated only a slight decrease of T4 and TSH concentrations in males (39) , whereas TR␣ Ϫ/Ϫ mice presented a progressive but severe reduction of circulating T4 and T3 between the third and the fourth week after birth (12) . In TR␣ 0/0 adult males, basal concentration of T4, but not T3 or TSH, is slightly but significantly reduced compared to wild-type mice. Furthermore, TSH and T4 suppression by increasing doses of T3 is more profound in TR␣ 0/0 than in wild-type mice (25) . In adult TR␣ 0/0 ␤ Ϫ/Ϫ mice, the concentrations of serum T4, T3, and TSH were increased 14-fold, 13-fold, and more than 200-fold respectively, compared to those of wild-type mice. These levels are comparable with those previously reported for TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ animals (11-, 30-, and 60-to 160-fold, respectively) (16) or 3-week-old TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice (7-, 20-, and more than 100-fold, respectively) (14) . Reduced growth rate and delayed bone maturation in TR␣ 0/0 and TR␣ 0/0 ␤ ؊/؊ mice. The growth of TR␣ 0/0 males and their wild-type littermates was monitored over a two-month period. TR␣ 0/0 mice showed a reduced increase of body weight compared to wild-type animals, at all ages analyzed, in both 129Sv (not shown) and C57BL/6 genetic backgrounds (Fig.  3A) . The time course of linear growth displayed similar differences (Fig. 3B) , showing that alteration of body growth fully accounts for the weight differences and that the TR␣ 0 mutation does not result in an abnormal weight-to-length ratio. TR␤ Ϫ/Ϫ mice displayed no difference in weight or length growth compared to that of the wild type (Fig. 3A and B) The growth of TR␣ 0/0 ␤ Ϫ/Ϫ mice was further reduced compared to the TR␣ 0/0 mutants, though no difference could be observed at birth. Weight reductions of 50 and 30% were observed in mice at weaning time and in adult mice, respectively, compared to wild-type mice (Fig. 3C) .
The synthesis of GH has been shown to be regulated by TH and to be decreased in TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ mice (16), which display marked growth retardation. We compared the expressions of the GH mRNA in the pituitary glands of wild-type, TR␣ 0/0 , and TR␣ 0/0 ␤ Ϫ/Ϫ mice. As shown in Fig. 3D , the amount of GH RNA was not altered in TR␣ 0/0 mice but was markedly reduced in double-knockout animals. These data suggest that the reduced growth observed in TR␣ 0/0 mice may not be due to a reduced production of GH.
Since linear growth was affected in TR␣ 0/0 mice, we studied endochondral ossification in their long bones. For this purpose, anatomical and histological analyses were performed. In 3-week-old TR␣ 0/0 animals at weaning, the ends of metatarsals and phalanges of the foot, the condyles and growth plate of the femur, and the growth plates of the tibia and fibula stained positively for cartilage with alcian blue (Fig. 4A) . In wild-type mice, alcian blue staining was markedly diminished and replaced by alizarin red staining in these areas, indicating that bone formation and mineralization were more advanced than in TR␣ 0/0 animals. Furthermore, ossification of the patella was delayed in TR␣ 0/0 mice relative to that in wild-type mice (Fig.  4A) . Similar evidence of delayed bone formation and mineralization was seen in the upper limbs of 3-week-old TR␣ 0/0 mice (data not shown). Goldner staining of undecalcified longitudinal sections of tibias revealed that the ossification of the epiphyses was delayed in TR␣ 0/0 mice, and the density of trabecular bone in the metaphyses was markedly lower than in control mice (Fig. 4B) . Histological analyses demonstrated that tibial growth plates from TR␣ 0/0 mice were grossly disorganized compared to those of wild-type animals (Fig. 4B, C , and D), and similar findings were observed in other growth plates throughout the upper and lower limbs of TR␣ 0/0 mice (data not shown). In particular, proliferating growth plate chondrocytes failed to form discrete columns and the hypertrophic zone was markedly diminished and morphologically indistinct in TR␣ 0/0 mice compared to wild-type mice, suggesting that hypertrophic chondrocyte differentiation failed to progress normally in TR␣ 0/0 mice. Furthermore, the degree of alcian blue staining of the growth plate cartilage matrix in TR␣ 0/0 mice was diminished and patchy compared to that in wild-type animals, supporting the view that epiphyseal growth plate architecture is disorganized and endochondral ossification is disrupted in TR␣ 0/0 mice ( Fig. 4C and D) . In TR␣ 0/0 ␤ Ϫ/Ϫ mice, a similar phenotype was observed (data not shown). These alterations were similar to those described previously for TR␣ Ϫ/Ϫ and TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice (12, 14) and are reminiscent of abnormalities in epiphyseal growth plates of hypothyroid rats (34) .
TR␣
0/0 ␤ ؊/؊ mice display severe hypothermia. TH plays a crucial role in the control of thermogenesis, and hypothyroidism results in decreased oxygen consumption and heat production (13) . We examined the temperatures of adult wild-type and mutant mice, using both a rectal probe and a temperaturesensitive probe implanted under the skin. The two techniques provided similar data. The mean body temperature of TR␤ Ϫ/Ϫ mice was similar to that of wild-type mice, but it was 0.4°C lower in TR␣ 0/0 mice (Fig. 5) . Interestingly, the mean body temperature of TR␣ 0/0 ␤ Ϫ/Ϫ animals was dramatically decreased (Ϫ4°C) relative to that of the wild type (Fig. 5) . These data suggest functional redundancy between the TR␤ and the TR␣ loci in the control of basal body temperature. plates from wt and TR␣ 0/0 mice; a section through the whole growth plate (magnification, ϫ200) is shown in panel C and a section containing the distal half of the growth plate (magnification, ϫ400) is shown in panel D. Black arrows, resorption front which separates the growth plate from underlying primary spongiosum; e, epiphysis; ps, primary spongiosum; rz, reserve zone chondrocytes; pz, proliferative zone; hz, hypertrophic zone.
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FUNCTIONS OF TR␣ LOCUS PRODUCTSin mice lacking both TR␤1 and TR␤2, but not in mice lacking TR␤2 only or TR␣1 (1, 11) , suggesting that TR␤1 is the only mediator of this T3-dependent function. However, the role of TR␣2 and the effect of the double knockout on the integrity of hearing have not been documented. We therefore measured the ABR threshold in TR␣ 0/0 and TR␣ 0/0 ␤ Ϫ/Ϫ mice. Whereas at low or middle frequencies TR␣ 0/0 mice had a normal hearing threshold, they exhibited a marked loss of sensitivity at high tone frequencies (Fig. 6) . In TR␣ 0/0 ␤ Ϫ/Ϫ mice, the loss of hearing threshold was significantly more severe than that observed in TR␤ Ϫ/Ϫ animals. These data suggest that, although the TR␤1 receptor is the major mediator of T3 action, in addition the integrity of the TR␣ gene is required to achieve full function of the auditory apparatus.
The intestinal phenotype is mildly altered in TR␣ 0/0 mice compared to that of TR␣ ؊/؊ mice. In mammals, the small intestine is lined by a continuously renewable population of epithelial cells. The pluripotent crypt stem cells give rise to immature cells that migrate and differentiate in the villus compartment and die after exfoliation at the villus tip. It was previously demonstrated that TR␣ Ϫ/Ϫ mice displayed a strong impairment of postnatal intestinal development (14, 28) . It is noteworthy that the intestine is one of the few organs where the TR⌬␣ and the TR␣ isoforms are coexpressed. In order to differentiate functions of the TR␣1/␣2 and TR⌬␣1/⌬␣2 isoforms in the intestine epithelium, we carried out a comparative investigation of morphofunctional parameters in TR␣ 0/0 , TR␣
Ϫ/Ϫ
, and wild-type mice. The size of the small intestine mucosa was reduced in TR␣ 0/0 mutants compared to that of wild-type animals. This was mainly due to the reduced lengths of the villi, resulting from a decreased number of epithelial cells per crypt-villus axis ( Fig. 7A and B) . These features were more strongly affected in the TR␣ Ϫ/Ϫ mice (Fig. 7C) . The proliferation and differentiation parameters of the epithelial cells also indicated a stronger impairment in TR␣ Ϫ/Ϫ than in TR␣ 0/0 mice (27a). In contrast to the TR␣ Ϫ/Ϫ mutant animals that displayed a thinning of the smooth muscular layers (12, 28) , TR␣ 0/0 mutants appeared normal in this respect. Taken together, these data strongly suggest that the severity of the intestinal phenotype correlates mostly with the persistence of the TR⌬␣ transcripts and not with the absence of TR␣1 and TR␣2 isoforms. distal ileum than that observed in TR␣ Ϫ/Ϫ mice (14, 28) . When we analyzed the distal ilea of TR␣ 0/0 ␤ Ϫ/Ϫ versus those of TR␣ 0/0 mice, no obvious morphological difference was observed ( Fig. 7B and D) and no statistically significant difference was found in the number of epithelial cells per crypt-villus axis. In contrast, in the ilea of TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice, the number of epithelial cells was further decreased compared with that of TR␣ Ϫ/Ϫ mice ( Fig. 7C and E) and the morphology was dramatically altered (Fig. 7E) , and TR␣ 0/0 mice, using the following antisera: anti-C␣1 raised against the common C-terminal part of TR␣1 and TR⌬␣1, anti-C␣2 raised against the common C-terminal part of TR␣2 and TR⌬␣2 but different from TR␣1, and anti-N␣ raised against the N-terminal part common to TR␣1 and TR␣2. No staining was obtained with the anti-C␣2 antibody in any genotypes (data not shown), whereas the expression of TR␣2 and TR⌬␣2 mRNAs has been demonstrated by semiquantitative RT-PCR (28), Northern blotting, and RNase protection (this study) in wild-type mice. As this antiserum was used successfully in immunocytochemical detection of TR⌬␣2 and TR␣2 proteins in transfected cells (data not shown), the failure to detect these proteins in the small intestine probably results from their very low concentration in this tissue.
Using the anti-N␣ antiserum, we observed a nuclear labeling in muscle layers of wild-type mice (Fig. 8A to D) , but no staining was observed in the epithelium or mesenchyme (Fig.  8B and C) . No positive cells were detected in TR␣ 0/0 or TR␣ Ϫ/Ϫ mice (Fig. 8E to H and I to L). By semiquantitative RT-PCR, it was previously shown that in smooth muscle layers only the TR␣1 RNA was detected (28) . Consequently, the signal detected with the anti-N␣ antibody in this tissue can be attributed to TR␣1. In the same experiment, the TR␣1 mRNA was found in the epithelium and connective tissues, whereas the TR␣2 mRNA was found only in the epithelium (28) ; therefore, we assume that the corresponding proteins are expressed in these tissue regions but at levels undetectable by this technique.
Using the anti-C␣1 antibody, we detected a strong nuclear signal in the differentiated epithelial cells of the villi in wildtype mice (Fig. 9A and B) . Only a faint signal could be detected in the undifferentiated epithelial cells of crypts, in the lamina propria, and in smooth muscle cells (Fig. 9C and D) . However, unlike the signal detected with the anti-N␣ reagent, this staining persisted in TR␣ Ϫ/Ϫ mice (Fig. 9I to L) , which retain the expression of TR⌬␣ transcripts, and disappeared in TR␣ 0/0 mice ( Fig. 9E to H ). These observations demonstrate that the protein labeled by the anti-C␣1 reagent is TR⌬␣1. They also suggest that, unlike the anti-N␣ antibody, the anti-C␣1 antibody is unable to recognize the TR␣1 protein, presumably due to the small amount of this protein in the distal ileum, and to the reduced accessibility of the target epitope in the tight conformation of the ligand binding domain. Altogether, these data indicate that in wild-type mice, the TR␣1 protein is mainly located in the nuclei of smooth muscle cells, whereas the TR⌬␣1 protein is mainly present in the nuclei of differentiated epithelial cells. It is worth noting that in TR␣ Ϫ/Ϫ undifferentiated and differentiated epithelial cells have similar nuclear labeling.
The activity of TR⌬␣ proteins is down-regulated by TR␣1 via the proteasome pathway. Our data show that the deleterious activity of the TR⌬␣ isoforms is triggered by the inactivation of the TR␣1 and TR␣2 genes. To clarify the molecular mechanisms which could account for this gene inactivationdependent activity, we tested the possibility that TR␣1 and TR␣2 could interfere with the synthesis or degradation of the TR⌬␣ isoforms, thereby modulating their activity. For this purpose, we measured the expression of the TR⌬␣1 protein in HeLa cells after cotransfection of a TR⌬␣1 expression vector together with either an empty vector or a vector expressing either TR␣1 or TR␣2. Figure 10 shows that, while the amount of TR⌬␣1 transcripts was unaffected by the coexpression of the TR␣1 protein (Fig. 10C) , the amount of TR⌬␣1 protein was reduced by increasing amounts of TR␣1 (Fig. 10A) . This effect was independent of the presence of T3 (data not shown). In contrast to these data, the expression of small amounts of TR␣2 did not produce any decrease in the amount of TR⌬␣1 protein (Fig. 10B) . It is noteworthy that expression of TR␤1 did not change the amount of TR⌬␣1 (data not shown). In order to show that degradation, and not the rate of protein synthesis, accounted for the reduction in the amount of the TR⌬␣1 protein, we tested the abilities of different permeant protease inhibitors to prevent this effect. When cotransfected cells were treated with lactacystin, a potent inhibitor of the proteasome pathway (9), the amount of TR␣1 protein was not changed, but the amount of TR⌬␣1 protein was considerably increased, reaching levels higher than those observed in the absence of TR␣1 (Fig. 10D) . These data suggest that TR␣1 triggers the degradation of the TR⌬␣1 protein through a proteasome-dependent pathway.
DISCUSSION
The TR␣ locus encodes the TR␣1 receptor, whose targeted inactivation results in bradycardia and a slight decrease in body temperature (39) . This locus also generates the TR␣2 variant, which cannot bind T3, poorly heterodimerizes with RXRs, and does not contain any transactivation domain. Transfection studies have shown that the TR␣2 protein can inhibit the transcriptional activity of TRs. The TR␣2 transcript is present in all mammalian tissues and is generally more abundant than the TR␣1 transcript, at least at the level of whole organ analysis (22) . Despite these many data, the in vivo function of the TR␣2 protein remains unknown. In addition to TR␣1 and TR␣2, we have identified the TR⌬␣1 and TR⌬␣2 transcripts, which are expressed in murine embryonic stem cells and in intestine, lung, and brain tissues of adult mice. The proteins encoded by these transcripts do not bind T3 or DNA but inhibit the transcriptional activity of several nuclear receptors when they are associated with RXR partners (6) . Their in vivo function is unknown. Several genetic modifications of the TR␣ locus which have been generated in a mouse now provide tools with which to obtain insights into the functions of these different products. The goal of this discussion is to draw some conclusions from the comparison of the phenotypes observed in the different TR␣ gene knockout mice. For the sake of clarity, we have indicated in Fig. 2C the TR␣ isoforms which are expressed or abolished in the different knockout strains.
TR␣1 and TR␤s cooperate to regulate TSH production.
Abolishing a TR␤1, TR␤2, TR␤3 and TR⌬␤3, or TR␤2 only has been shown to result in altered TH-dependent feedback regulation of TSH production by T3 (1, 37) . In contrast, abolishing the TR␣1/⌬␣1 isoforms in TR␣1 Ϫ/Ϫ mice (R. E. Weiss, O. Chassande, P. E. Macchia, K. Cua, J. Samarut, and S. E. Refetoff, submitted for publication), TR␣1/␣2 in TR␣ Ϫ/Ϫ mice (12), or TR␣1/␣2/⌬␣1/⌬␣2 in TR␣ 0/0 mice (25) results in mild alterations in the serum concentrations of TH and TSH, indicating that the TR␣ isoforms may play minor roles in this feedback control. However, TR␣1
Ϫ/Ϫ mice display decreased T4 and TSH levels, suggestive of secondary hypothyroidism, while TR␣ 0/0 mice have decreased T4 but normal TSH levels, indicating increased sensitivity of the pituitary to TH. Moreover, careful examination of central responses to varying doses of T3 in TR␣ 0/0 mice reveals increased sensitivity to TH (25) . Altogether, these data suggest that the TR␣2 isoform weakly antagonizes the activity of TR␤s in thyrotroph cells. In the absence of any true TRs, in TR␣1 14) , and TR␣ 0/0 ␤ Ϫ/Ϫ mice, TSH reaches very high levels despite large amounts of TH, independently of the presence of non-T3-binding TR isoforms. This shows that in thyrotroph cells, TR␣2 could modulate TSH production only in the presence of a TR␤-mediated T3 response.
TR␣1, TR␣2, and TR␤s cooperate to maintain basal body temperature. Mice lacking the TR␣1/⌬␣1 isoforms (TR␣1 Ϫ/Ϫ ) have a body temperature 0.5°C lower than that of wild-type mice (18) . We show here that TR␣ 0/0 mice display a similar deficit, suggesting that abolishing TR␣2 does not alter thermogenesis, at least under basal conditions. TR␤ Ϫ/Ϫ mice have normal body temperatures suggesting that the contribution of the TR␤ isoforms in the T3-dependent basal thermogenesis is Ϫ/Ϫ and TR␣ 0/0 mice, this function is unraveled only in the absence of functional TR. The above data lead to the conclusion that the effects of TH on basal body temperature are mediated by the TR␣ and TR␤ nuclear receptors, that TR␣1, TR␤s, and TR␣2 isoforms exercise redundant functions in the control of thermogenesis, and that the persistence of only one of these isoforms is sufficient to maintain body temperature within a physiologic range.
TR␣2 is essential for normal body growth and bone maturation. Previous publications and our data have shown that in TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ , TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ , and TR␣ 0/0 ␤ Ϫ/Ϫ mice, the total absence of functional TH receptors results in a reduced growth rate and delayed bone maturation, independently of the presence of non-TH-binding isoforms from the TR␣ locus. This consensus is in agreement with the bone maturation delay observed in hypothyroid rats (34) . This simple observation contrasts with the complexity resulting from the analysis of the functions of individual TR␣ and TR␤ isoforms. Previous reports indicate that TR␤ Ϫ/Ϫ and TR␣1 Ϫ/Ϫ mice have normal growth rates and bone maturation (10, 14, 16, 39) . In contrast, combining some of the TR mutations results in a profound disruption of these processes, revealing functional redundancies between TR isoforms. One redundancy clearly occurs with TR␣1 and TR␤, which are both expressed in bone (2, 5, 31, 34) and which in combined but not individual knockouts result in bone maturation delay. The selective abolishing of TR␣1 in TR␣1 Ϫ/Ϫ mice does not result in obvious impairment of linear growth or bone maturation. However, in TR␣ Ϫ/Ϫ (12) and TR␣ 0/0 (this paper) mice, devoid of both TR␣1 and TR␣2 isoforms, growth retardation and delayed skeletal development are observed. The skeletal phenotype of TR␣ 0/0 mice includes retarded ossification, failure of progression of hypertrophic chondrocyte differentiation, and disorganization of epiphyseal growth plate architecture, all features similar to those seen in hypothyroidism (34) . Importantly, circulating basal TH concentrations in TR␣ 0/0 mice were only mildly impaired and GH concentrations were unchanged compared to those of wild-type mice, supporting the notion that the deletion of the TR␣ gene fully accounts for this phenotype. On consideration of the TR isoforms that are expressed in the different knockout strains (Fig. 2C ), the skeletal phenotypes described can be proposed to result primarily from the abolishing of TR␣2, or the concomitant abolishing of both TR␣1 and TR␣2. Only when data concerning the TR␣2-specific mutation are available will it be possible to test this hypothesis further. Nevertheless, our data reveal the important role of TR␣2 in body growth and maturation of long bones. An interesting observation is that in bone, abolishing TR␣2, an isoform that is known to weakly inhibit T3 responses in vitro, paradoxically results in a phenotype which is similar to the skeletal consequences of profound hypothyroidism. This situation contrasts with the increased T3 response observed in the pituitary of TR␣ 0/0 mice (25) . The alteration of growth and bone maturation observed in TR␣1 Ϫ/Ϫ ␤ Ϫ/Ϫ and TR␣ 0/0 ␤ Ϫ/Ϫ mice could be attributed to impaired GH synthesis since these animals exhibit decreased amounts of GH transcripts in pituitary (reference 16 and the present study). In TR␣ 0/0 and TR␣ Ϫ/Ϫ mice, however, the GH transcript is expressed at a normal level; therefore, the bone phenotype may be the direct consequence of the TR␣ mutation within bone cells.
Deafness caused by loss of the TR␤ gene is not rescued by deletion of the TR␣ gene. In addition to confirming the importance of TR␤ in achieving normal hearing function, the present studies demonstrate that TR␣ may also play a role in the development of normal hearing. In fact, a reduced hearing ability was observed in TR␣ 0/0 mice compared to that of wildtype mice at higher frequencies. Although some elevation of ABR thresholds at 24 kHz is typical of C57BL/6J mice older than 2 to 3 months, the observed hearing loss in the TR␣ 0/0 mice is highly significant. Moreover, the TR␣ 0/0 ␤ Ϫ/Ϫ mouse was more severely deaf than the TR␤ Ϫ/Ϫ mouse. While these observations confirm the important role of TR␤ for the development of auditory function (12), they have also identified a contribution of TR␣ to the full integrity of hearing.
Unbalanced expression of TR⌬␣ isoforms results in improper intestinal development and precocious lethality. We have previously described the lethal phenotype of TR␣ Ϫ/Ϫ mice. The TR␣ Ϫ mutation abolishes the TR␣1 and TR␣2 transcripts but retains TR⌬␣ transcripts. We show in this study that TR⌬␣ transcripts are expressed in the small intestines of wildtype and TR␣ Ϫ/Ϫ but not of TR␣ 0/0 mice. Accordingly, using anti-␣1 C-terminal antibody, we detect the TR⌬␣ isoforms in the intestinal epithelial cells of wild-type and TR␣ Ϫ/Ϫ but not TR␣ 0/0 mice. This is the first time that the specificity of the staining observed in an immunocytochemical analysis of TRs is assessed by genetic arguments. Therefore, analysis of the products of the TR␣ locus reveals that the only molecular difference between the TR␣ Ϫ/Ϫ and TR␣ 0/0 mutations is the expression of the TR⌬␣ isoforms. Immunocytochemical analysis further shows that the expression of the TR⌬␣1 protein is expanded in the TR␣ Ϫ/Ϫ mice, extending all along the crypt and the villus. In vivo observations show that abolishing TR␣1 and TR␣2 in TR␣ Ϫ/Ϫ mice confers deleterious effects on the TR⌬␣ isoforms, suggesting that, under normal conditions (wild-type mice), the TR␣ products down-modulate the activity of the TR⌬␣ isoforms. Transfection experiments suggest that one mechanism by which TRs could control the activity of TR⌬␣ proteins is by triggering their rapid removal from the cells through the proteasome-mediated degradation. This mechanism would explain the increased intensity and extended expression domain of the TR⌬␣1 protein in the absence of TR␣1 in the intestines of TR␣ Ϫ/Ϫ mice. The mechanism by which TR⌬␣ proteins exert their toxic effects in the developing intestine is unclear. The persistence of a severe intestinal phenotype upon inactivation of the TR␤ gene in TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice implies that the molecular targets of the TR⌬␣ proteins are not only the TRs. We have previously suggested that other nuclear receptors, such as retinoic acid receptors, could be antagonized by TR⌬␣ products. At the level of the whole organism, the lethal phenotype observed in TR␣ Ϫ/Ϫ and TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice is indeed due to the persistence of TR⌬␣ isoforms since it can be rescued by their abolition in TR␣ 0/0 and TR␣ 0/0 ␤ Ϫ/Ϫ mice. Thus, the severe intestinal abnormalities and the lethality observed in TR␣ Ϫ/Ϫ and TR␣ Ϫ/Ϫ ␤ Ϫ/Ϫ mice are consequences of the persistence of TR⌬␣ isoforms, which are no longer under the control of the TR␣1 protein. These genetic and molecular analyses suggest that the TR⌬␣ isoforms have powerful, dosedependent toxic effects and that their level of expression must be tightly controlled. Altogether, these genetic analyses show that the non-T3-binding isoforms encoded from the TR␣ locus have important developmental and homeostatic functions.
In addition, our present and previously published data allow the prediction that a potential homozygous mutation in the TR␣ locus in humans, which would abolish all TR␣ isoforms, would be expected to result in a mild phenotype mainly characterized by (i) increased sensitivity to TH in the thyrotroph and liver and (ii) reduced sensitivity to TH in heart and bone, manifested as bradycardia, growth retardation, and bone maturation delay. Mutations restricted to the N-terminal moiety of the gene, sparing the TR⌬␣ isoforms, are expected to have severe pathologic consequences.
